HK1031222A1 - Camptothecin derivatives having antitumor activity - Google Patents

Camptothecin derivatives having antitumor activity

Info

Publication number
HK1031222A1
HK1031222A1 HK00107660A HK00107660A HK1031222A1 HK 1031222 A1 HK1031222 A1 HK 1031222A1 HK 00107660 A HK00107660 A HK 00107660A HK 00107660 A HK00107660 A HK 00107660A HK 1031222 A1 HK1031222 A1 HK 1031222A1
Authority
HK
Hong Kong
Prior art keywords
antitumor activity
camptothecin derivatives
camptothecin
derivatives
antitumor
Prior art date
Application number
HK00107660A
Other languages
English (en)
Inventor
Sergio Penco
Lucio Merlini
Paolo Carminati
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1031222A1 publication Critical patent/HK1031222A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK00107660A 1999-03-09 2000-11-29 Camptothecin derivatives having antitumor activity HK1031222A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99830124A EP1044977B1 (en) 1999-03-09 1999-03-09 Camptothecin derivatives having antitumor activity

Publications (1)

Publication Number Publication Date
HK1031222A1 true HK1031222A1 (en) 2001-06-08

Family

ID=8243303

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107660A HK1031222A1 (en) 1999-03-09 2000-11-29 Camptothecin derivatives having antitumor activity

Country Status (39)

Country Link
US (2) US6242457B1 (pl)
EP (1) EP1044977B1 (pl)
JP (1) JP4610743B2 (pl)
KR (1) KR100702085B1 (pl)
CN (1) CN1139592C (pl)
AR (1) AR022860A1 (pl)
AT (1) ATE216998T1 (pl)
AU (1) AU774174B2 (pl)
BG (1) BG65032B1 (pl)
BR (1) BR0008840B1 (pl)
CA (1) CA2362760C (pl)
CO (1) CO5180590A1 (pl)
CZ (1) CZ304465B6 (pl)
DE (1) DE69901379T2 (pl)
DK (1) DK1044977T3 (pl)
EA (1) EA003605B1 (pl)
EE (1) EE04679B1 (pl)
EG (1) EG23999A (pl)
ES (1) ES2175919T3 (pl)
HK (1) HK1031222A1 (pl)
HR (1) HRP20010667B1 (pl)
HU (1) HU229506B1 (pl)
IL (2) IL144958A0 (pl)
IS (1) IS2003B (pl)
ME (2) MEP4008A (pl)
MX (1) MXPA01009081A (pl)
NO (1) NO328363B1 (pl)
NZ (1) NZ513393A (pl)
PE (1) PE20001485A1 (pl)
PL (1) PL222208B1 (pl)
PT (1) PT1044977E (pl)
RS (1) RS50405B (pl)
SI (1) SI1044977T1 (pl)
SK (1) SK287561B6 (pl)
TN (1) TNSN00045A1 (pl)
TR (1) TR200102603T2 (pl)
TW (1) TWI272272B (pl)
WO (1) WO2000053607A1 (pl)
ZA (1) ZA200107408B (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4790911B2 (ja) 1999-01-13 2011-10-12 アルケミア オンコロジー ピーティワイ リミテッド 薬物の効力を増強するための組成物および方法
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
FR2794123B1 (fr) * 1999-05-28 2001-07-27 Aventis Pharma Sa Preparation de derives de la camptothecine et de la nothapodytine
US6352996B1 (en) * 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
US20040029906A1 (en) * 2001-07-31 2004-02-12 Michael Christman Inhibitors of dna polymerase sigma
JP2005505540A (ja) * 2001-08-27 2005-02-24 メディテック　リサーチ　リミテッド 改善された治療プロトコール
WO2003033525A1 (en) * 2001-10-12 2003-04-24 Debio Recherche Pharmacuetique S.A. Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
ITRM20020305A1 (it) 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Camptotecine con anello lattonico modificato.
ITRM20020306A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
CN1929842A (zh) * 2004-03-26 2007-03-14 诺瓦提斯公司 喜树碱衍生物以固定给药方案治疗增生性疾病的用途
CN1946421B (zh) 2004-04-27 2013-07-17 威尔斯达特生物制剂公司 使用病毒和喜树碱进行的癌症治疗
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
ITRM20040241A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
CN100334089C (zh) * 2004-07-21 2007-08-29 王洋 一种9－硝基喜树碱的生产方法
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
US8975248B2 (en) 2004-12-15 2015-03-10 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Combinations of therapeutic agents for treating cancer
PT1828196E (pt) 2004-12-21 2012-11-19 Sigma Tau Ind Farmaceuti Processo estereo-selectivo e formas cristalinas de uma camptotecina
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
JP5190958B2 (ja) 2005-07-14 2013-04-24 ウェルスタット バイオロジクス コーポレイション ウイルス、フルオロピリミジンおよびカンプトテシンを使用した癌の処置
EP1912658B1 (en) * 2005-07-27 2017-01-25 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
RU2008108894A (ru) * 2005-08-10 2009-09-20 Новартис АГ (CH) Композиции 7-(трет-бутокси)иминометилкамптотецина
JP5627181B2 (ja) * 2005-09-07 2014-11-19 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
ATE548038T1 (de) * 2005-12-21 2012-03-15 Sigma Tau Ind Farmaceuti Behandlung von arzneiresistenten tumoren
JP5596924B2 (ja) * 2006-02-17 2014-09-24 カスケード プロドラッグ インコーポレイテッド ビンカアルカロイドｎ酸化物および類似体による過剰増殖疾患の処置
CA2658015A1 (en) 2006-03-30 2007-10-11 Diatos S.A. Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
KR20090115856A (ko) * 2007-02-01 2009-11-09 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 캄포테신 유도체를 함유하는 약학적 조성물
WO2008098701A1 (en) * 2007-02-13 2008-08-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
MX2010001084A (es) * 2007-08-01 2010-03-25 Sigma Tau Ind Farmaceuti Tratamiento de tumores pediatricos.
EP2096113A1 (en) * 2008-02-05 2009-09-02 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. 9-substituted camptothecin derivatives as antitumor compounds
TWI482621B (zh) 2009-12-23 2015-05-01 Sigma Tau Ind Farmaceuti 青蒿素基藥物與其他化學治療劑的抗癌組合物
CN108135917B (zh) 2015-09-25 2021-07-09 Zy医疗 基于包含多糖-维生素缀合物的颗粒的药物制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
DK0612248T3 (da) * 1991-11-15 2003-12-08 Smithkline Beecham Corp Præparat, der indeholder cisplatin og topotecan som antitumormiddel
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
GB9512670D0 (en) * 1995-06-21 1995-08-23 Sod Conseils Rech Applic Camptothecin analogues
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
BR9711319B1 (pt) * 1996-08-19 2009-08-11 derivados de camptotecina altamente lipofìlicos.

Also Published As

Publication number Publication date
EE04679B1 (et) 2006-08-15
MEP4008A (xx) 2010-02-10
DE69901379D1 (de) 2002-06-06
KR100702085B1 (ko) 2007-04-02
MXPA01009081A (es) 2002-08-30
EP1044977B1 (en) 2002-05-02
BG105810A (en) 2002-06-28
ZA200107408B (en) 2002-05-29
YU64301A (sh) 2005-07-19
TWI272272B (en) 2007-02-01
ME00017B (me) 2010-06-10
JP2002539128A (ja) 2002-11-19
EA003605B1 (ru) 2003-06-26
BG65032B1 (bg) 2006-12-29
EP1044977A1 (en) 2000-10-18
US6589939B2 (en) 2003-07-08
CA2362760C (en) 2009-08-18
JP4610743B2 (ja) 2011-01-12
US20010008939A1 (en) 2001-07-19
HUP0200210A3 (en) 2004-03-29
EE200100466A (et) 2002-12-16
BR0008840B1 (pt) 2011-12-27
PL222208B1 (pl) 2016-07-29
SK287561B6 (sk) 2011-02-04
PE20001485A1 (es) 2000-12-07
NO20014128D0 (no) 2001-08-24
CZ20013077A3 (cs) 2002-01-16
IL144958A0 (en) 2002-06-30
NO328363B1 (no) 2010-02-01
PT1044977E (pt) 2002-09-30
NO20014128L (no) 2001-08-24
IL144958A (en) 2009-08-03
US6242457B1 (en) 2001-06-05
SK11642001A3 (sk) 2002-01-07
IS2003B (is) 2005-04-15
PL355094A1 (pl) 2004-03-22
TR200102603T2 (tr) 2002-01-21
KR20010102519A (ko) 2001-11-15
CO5180590A1 (es) 2002-07-30
RS50405B (sr) 2009-12-31
HRP20010667B1 (en) 2003-06-30
HU229506B1 (en) 2014-01-28
HUP0200210A2 (hu) 2002-05-29
HRP20010667A2 (en) 2002-08-31
ES2175919T3 (es) 2002-11-16
DK1044977T3 (da) 2002-07-08
BR0008840A (pt) 2002-01-08
ATE216998T1 (de) 2002-05-15
WO2000053607A1 (en) 2000-09-14
CN1343209A (zh) 2002-04-03
CN1139592C (zh) 2004-02-25
EG23999A (en) 2008-03-19
SI1044977T1 (en) 2002-08-31
DE69901379T2 (de) 2002-11-07
EA200100954A1 (ru) 2002-04-25
TNSN00045A1 (fr) 2005-11-10
CA2362760A1 (en) 2000-09-14
IS6031A (is) 2001-07-31
AU774174B2 (en) 2004-06-17
AU3160400A (en) 2000-09-28
NZ513393A (en) 2003-04-29
AR022860A1 (es) 2002-09-04
CZ304465B6 (cs) 2014-05-21

Similar Documents

Publication Publication Date Title
EG23999A (en) Camptothecin derivatives having antitumor activity
EG23817A (en) 4-Phenyl-pyridine derivatives
IL147924A0 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
IL148167A0 (en) Amino-triazolopyridine derivatives
IL146100A0 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
GC0000183A (en) 3-Phenyl-pyridine derivatives
GC0000338A (en) 5-Phenyl-pyrimidine derivatives
HK1044940A1 (zh) 異噁唑咪唑羧酰胺衍生物
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
HU0003938D0 (en) Quinolin-4-yl derivatives
IL138777A0 (en) Quinolin-4-yl derivatives i
GB0026485D0 (en) ›-Carboline derivatives
HK1045987A1 (zh) 3-氨基-2-苄基-1-苯基-丙烷衍生物
HK1048638A1 (zh) Cyclopenteneone衍生物
GC0000256A (en) Ethanesulfonyl-piperidine derivatives
HK1045698A1 (zh) 阿維菌素衍生物
AP2001002327A0 (en) 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
GB0131034D0 (en) Benzocyclodecane derivatives with antitumor activity
GC0000200A (en) Camptothecin derivatives having antitumor activity
AU5769500A (en) Ucf116 derivatives as antitumor agents
GB9907134D0 (en) Antimor napthylcombretastatin derivatives
HK1043987A1 (zh) 硫-羥吲衍生物

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180309